GSK Says It Settled Zantac-Ranitidine Cancer Case Before July California Trial
LONDON — Drug manufacturer GlaxoSmithKline PLC (GSK) has announced that it has agreed to settle a Zantac-ranitidine bellwether case that was scheduled to go to trial on July 24....To view the full article, register now.
Already a subscriber? Click here to view full article